Russell Investments Group Ltd. Decreases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Russell Investments Group Ltd. reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 5.8% during the first quarter, Holdings Channel.com reports. The institutional investor owned 325,776 shares of the company’s stock after selling 19,955 shares during the period. Russell Investments Group Ltd.’s holdings in Henry Schein were worth $24,598,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Sei Investments Co. raised its position in Henry Schein by 5.9% during the first quarter. Sei Investments Co. now owns 389,789 shares of the company’s stock valued at $29,437,000 after purchasing an additional 21,740 shares during the period. Foyston Gordon & Payne Inc raised its position in Henry Schein by 99.5% during the first quarter. Foyston Gordon & Payne Inc now owns 144,102 shares of the company’s stock valued at $10,883,000 after purchasing an additional 71,870 shares during the period. Forsta AP Fonden grew its stake in shares of Henry Schein by 8.9% during the first quarter. Forsta AP Fonden now owns 24,500 shares of the company’s stock valued at $1,850,000 after buying an additional 2,000 shares during the last quarter. Illinois Municipal Retirement Fund grew its stake in shares of Henry Schein by 0.6% during the first quarter. Illinois Municipal Retirement Fund now owns 95,899 shares of the company’s stock valued at $7,242,000 after buying an additional 575 shares during the last quarter. Finally, Nuance Investments LLC grew its stake in shares of Henry Schein by 28.5% during the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock valued at $132,552,000 after buying an additional 388,843 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Up 5.1 %

NASDAQ HSIC traded up $3.43 during midday trading on Wednesday, hitting $71.02. 966,625 shares of the company traded hands, compared to its average volume of 1,078,540. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The company has a market cap of $9.09 billion, a PE ratio of 23.93, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87. The company’s 50-day simple moving average is $68.53 and its 200-day simple moving average is $72.07. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.09. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.21 EPS. As a group, equities research analysts forecast that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on HSIC shares. Barrington Research reaffirmed an “outperform” rating and set a $92.00 target price on shares of Henry Schein in a research note on Friday, July 5th. Evercore ISI cut their target price on Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a research note on Tuesday, July 9th. Piper Sandler reaffirmed an “overweight” rating and set a $86.00 target price on shares of Henry Schein in a research note on Friday, June 21st. Finally, UBS Group dropped their price objective on Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $80.73.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.